LyondellBasell (LYB)
NYSEMaterialsSpecialty ChemicalsSnapshot 2026-07-08
$55.72+2.04%
Close 2026-07-08 · 1-day change
Reading LYB? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track LYB free→NYSEMaterialsSpecialty ChemicalsSnapshot 2026-07-08
Reading LYB? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track LYB free→A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This investment represents a turnaround play, as LYB is currently navigating through loss-making conditions and management volatility. The long-term thesis is in a watch state, reflecting uncertainty in its recovery trajectory.
The market appears to have priced in a low expectations gap, indicating that investors are not overly optimistic about LYB's near-term performance. Valuation suggests that LYB is seen as cheap compared to peers, but the fundamentals are not currently supporting this valuation.
Fundamentals are likely to remain under pressure in the near term, given the company's recent loss-making performance and mixed execution on management priorities. The ongoing cash improvement plan has not yet delivered positive cash flow, which raises concerns about financial stability.
The future performance of LYB hinges on several factors, including guidance updates from management and the performance of sector bellwethers like LIN, SHW, and ECL. Positive momentum in the Materials sector could provide support, while any negative guidance could lead to further downward pressure.
In the next 1 to 3 years, LYB's performance will depend heavily on its ability to improve cash flow and navigate sector challenges. Not investment advice.
The most important moves since the prior daily snapshot.
risk label changed from 'moderate' to 'elevated'.
Yes, our read has strengthened. The latest earnings beat supports a more positive outlook. Higher polyethylene prices help cash generation through cost-advantaged production. There are no new threats to the thesis.
as of 2026-07-08
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: Better EBITDA shows good cost management and strong demand. This can boost investor trust.
Confirms:Q2 EBITDA rises above $600 million. This shows less supply and better pricing.
Disproves:Q2 EBITDA stays under $568 million. This shows ongoing market problems.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Why it matters: A strong EBITDA shows better performance and cash flow during tough market times.
Confirms:Q2 EBITDA, not counting some items, is over $615 million.
Disproves:Q2 EBITDA, not counting some items, is below $615 million.
Why it matters: Hitting this target would boost cash flow and financial health for future growth.
Confirms:Cash Improvement Plan aims for $1.3 billion by the end of 2026.
Disproves:Cash Improvement Plan falls short of $1.3 billion by year-end 2026.
Why it matters: Progress in this plan is crucial for reducing costs and improving margins in a tough market.
Confirms:Management reports good progress in the Cash Improvement Plan. The score is now above 50.
Disproves:The progress score is still below 35. This shows ongoing cost management issues.
Why it matters: Raising the cash target shows that management wants better financial health.
Confirms:Management will share a higher cash generation target in the next earnings call.
Disproves:No mention of a cash generation target increase in the next earnings call.
Why it matters: Progress on this plan is crucial for financial health. It affects cash flow stability.
Confirms:Cash from operating activities exceeds $600M in Q2 2026.
Disproves:Cash from operating activities is below $600M in Q2 2026.
Why it matters: Reaching this target shows LyondellBasell is improving cash generation. It is key for future growth.
Confirms:Cash from operating activities reaches or exceeds $1.3B in Q2 2026.
Disproves:Cash from operating activities falls below $1.3B in Q2 2026.